An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population

A total of 1080 individual patient samples (158 positive serology samples from confirmed, predominantly mildly symptomatic COVID-19 patients and 922 serology negative including 496 collected pre-COVID) from four states in Australia were analysed on four commercial SARS-CoV-2 serological assays targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehrhahn, Michael C., Brown, Suzanne J., Newcombe, James P., Chong, Smathi, Evans, Jenny, Figtree, Melanie, Hainke, Laurence, Hueston, Linda, Khan, Sadid, Marland, Elizabeth, O’Sullivan, Matthew V.N., Powell, Helen, Roy, Jhumur, Waring, Lynette, Yu, Megan, Robson, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968170/
https://www.ncbi.nlm.nih.gov/pubmed/33770657
http://dx.doi.org/10.1016/j.jcv.2021.104797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968170/
https://www.ncbi.nlm.nih.gov/pubmed/33770657
http://dx.doi.org/10.1016/j.jcv.2021.104797

Ejemplares similares